We are live on ! Find out more
CKPT

Checkpoint Therapeutics

Delisted

CKPT was delisted on the 29th of May, 2025.

53 hedge funds and large institutions have $34M invested in Checkpoint Therapeutics in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

146% more capital invested

Capital invested by funds: $13.8M → $34M (+$20.2M)

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

18% more funds holding

Funds holding: 4553 (+8)

0.67% more ownership

Funds ownership: 1.45%2.12% (+0.67%)

Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
20
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$8.23M +$1.77M +73,888 +32%
CH
2
CVI Holdings
Delaware
$7.03M +$6.3M +262,255 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$6.15M +$1.74M +72,477 +46%
SM
4
Sabby Management
Florida
$2.5M +$2.24M +93,124 New
State Street
5
State Street
Massachusetts
$1.78M +$189K +7,876 +13%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.56M +$247K +10,280 +21%
Northern Trust
7
Northern Trust
Illinois
$1.36M -$6.77K -282 -0.6%
FWM
8
Frontier Wealth Management
Missouri
$949K +$850K +35,398 New
N
9
Nuveen
North Carolina
$575K +$49.2K +2,047 +11%
IIM
10
Ironwood Investment Management
Massachusetts
$365K +$327K +13,605 New
Charles Schwab
11
Charles Schwab
California
$332K +$14.1K +587 +5%
Wells Fargo
12
Wells Fargo
California
$330K +$23.4K +976 +9%
Renaissance Technologies
13
Renaissance Technologies
New York
$316K +$39.4K +1,640 +16%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$289K +$41.3K +1,721 +19%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$214K -$84.9K -3,534 -31%
SAG
16
Spotlight Asset Group
Illinois
$214K
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$183K +$35.3K +1,469 +27%
PAS
18
Park Avenue Securities
New York
$144K
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$144K +$144 +6 +0.1%
TRCT
20
Tower Research Capital (TRC)
New York
$124K +$92.2K +3,840 +481%
FAM
21
Fenimore Asset Management
New York
$87K
JP Morgan Chase
22
JP Morgan Chase
New York
$83K -$26.3K -1,095 -27%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$83K
VF
24
Virtu Financial
New York
$81K +$39K +1,624 +115%
BRWA
25
B. Riley Wealth Advisors
Florida
$80K +$70.8K +2,950 New

CKPT Hedge Fund Activity: Q3 2020 in Review

53 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2020, worth a combined $34M — up 146% from $13.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CKPT positions and 3 closed out — a net gain of 8 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $6.3M. The largest seller was Acadian Asset Management, cutting an estimated $84.9K.

  • 53 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2020, up from 45 in Q2 2020.
  • Funds reported $34M of Checkpoint Therapeutics stock for Q3 2020, up 146% quarter-over-quarter.
  • 11 funds opened new Checkpoint Therapeutics positions in Q3 2020 and 3 closed out, a net change of +8 holders.
  • The largest Checkpoint Therapeutics buyer in Q3 2020 was CVI Holdings, an estimated $6.3M added.
  • The largest Checkpoint Therapeutics seller in Q3 2020 was Acadian Asset Management, an estimated $84.9K sold.

Based on aggregated 13F filings for Q3 2020.